Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report

Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report

Novel mRNA and vector-based covid-19 vaccinations have shown high efficacy in preventing symptomatic COVID-19 infections. Compared with the number of performed vaccinations, rates of severe side effects seem low. Rare prothrombotic coagulation disorders with suspected association to ChAdOx1 nCoV-19...

Full description

Bibliographic Details
Main Authors:	Martin Koch, Sybille Fuld, Jan M. Middeke, Julia Fantana, Simone von Bonin, Jan Beyer-Westendorf
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2021-07-01
Series:	TH Open
Subjects:	thrombocytopenia platelet pathology / inherited aquired infectious diseases covid vaccination itp itp associated with covid vaccination itp associated with astrazeneca covid vaccination secondary itp
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731774

Similar Items

PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC
by: Francesco Rodeghiero
Published: (2021-04-01)

PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC
by: Francesco Rodeghiero
Published: (2021-04-01)

Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy
by: Konstantina Salveridou, et al.
Published: (2024-09-01)

Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review
by: Gian Marco Podda, et al.
Published: (2022-01-01)

Lifting the fog over ITP
by: Philip Young-Ill Choi
Published: (2020-04-01)

First report on health-related quality of life among children with chronic immune thrombocytopenia in Vietnam
by: Sang Ngoc Nguyen, PhD, et al.
Published: (2021-10-01)

Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines
by: Qasim H, et al.
Published: (2023-04-01)

Editorial: Immune thrombocytopenia (ITP)—diagnosis and treatment
by: Tomás José González-López
Published: (2024-03-01)

Understanding Immune Thrombocytopenia: Looking Out of the Box
by: Alexandra Schifferli, et al.
Published: (2021-06-01)

Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination
by: Emilie C. Collins, et al.
Published: (2021-10-01)

Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
by: Alex Shimanovsky, et al.
Published: (2016-01-01)

Response to rituximab in children and adults with immune thrombocytopenia (ITP)
by: Emily M. Harris, et al.
Published: (2021-08-01)

ITP following vaccination
by: Paula David, et al.
Published: (2020-10-01)

Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia
by: Bonnie J.B. Lewis, et al.
Published: (2021-11-01)

How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh)
by: Prantar Chakrabarti, et al.
Published: (2022-03-01)

Novel scientific approaches and future research directions in understanding ITP
by: Sarah M. Hicks, et al.
Published: (2020-04-01)

Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines [Letter]
by: Ali A, et al.
Published: (2023-06-01)

Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
by: Deirdra R. Terrell, et al.
Published: (2020-11-01)

The Outcome of Withholding Pharmacologic Treatment in Children with Acute ITP
by: Jalil I Alezzi, et al.
Published: (2019-10-01)

The Outcome of Withholding Pharmacologic Treatment in Children with Acute ITP
by: Jalil I Alezzi, et al.
Published: (2019-10-01)

Idiopathic Autoimmune Thrombocytopenic Purpura (ITP) in adult; review of 50 cases admitted to Baghdad teaching hospital.
by: Adil S. Al-Aqabi, et al.
Published: (2010-07-01)

Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
by: Monica Carpenedo, et al.
Published: (2023-02-01)

Is laparoscopy a safe and a cost effective alternative in the surgical management of idiopathic thrombocytopenic purpura (ITP)?
by: K.B. Galketiya, et al.
Published: (2017-02-01)

Partial splenic embolization for refractory thrombocytopenia
by: Irwin M. Best
Published: (2011-12-01)

Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis
by: Dorela Lame, et al.
Published: (2024-03-01)

Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination
by: Yimei Feng, et al.
Published: (2022-11-01)

Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag
by: Begum S. Koc, et al.
Published: (2024-08-01)

Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study
by: Arthur Mageau, et al.
Published: (2023-12-01)

Megakaryocytic dysfunction in immune thrombocytopenia is linked to autophagy
by: Rui-jie Sun, et al.
Published: (2019-03-01)

Endothelial alterations in a canine model of immune thrombocytopenia
by: Dana N. LeVine, et al.
Published: (2019-01-01)

Clinical Phenotype and Response to Different Lines of Therapy in Elderly with Immune Thrombocytopenia: A Retrospective Study
by: Mancuso S, et al.
Published: (2020-08-01)

Maternal Immune Thrombocytopenic Purpura Leading to Severe Neonatal Autoimmune Thrombocytopenia: Report of Two Cases
by: Khushwant Kaur, et al.
Published: (2024-10-01)

Pathogenesis-oriented approaches for the management of corticosteroid-resistant or relapsedprimary immune thrombocytopenia
by: Liu Xin-guang, et al.
Published: (2016-01-01)

Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association?
by: Maria L Lozano, et al.
Published: (2020-10-01)

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
by: Tsykunova G, et al.
Published: (2022-03-01)

Thrombocytopenia induced by clopidogrel: a rare adverse effect
by: Catarina Távora, et al.
Published: (2023-10-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma
by: Mengyi Du, et al.
Published: (2022-06-01)

Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center study
by: Mahsa Matinkia, et al.
Published: (2021-11-01)